CIRQILA
LIVE

Serial Number

79261899

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Apr 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CIRQILA Trademark

Serial Number: 79261899 • Registration: 5911437

CIRQILA is a trademark filed by NOVARTIS AG on April 27, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

April 27, 2019

Registration Date

November 19, 2019

Published for Opposition

September 3, 2019

Cancellation Date

August 6, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION PROCESSED BY IB
Jul 4, 2022 GPNX
INTERNATIONAL REGISTRATION RENEWED
Dec 22, 2021 RNWL
NOTIFICATION PROCESSED BY IB
Dec 12, 2021 GPNX
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 24, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 24, 2021 DETH
NOTIFICATION PROCESSED BY IB
Feb 21, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 13, 2020 FICS
FINAL DISPOSITION PROCESSED
Jan 13, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 19, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2019 NONP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2019 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2019 CNSA
APPLICATION FILING RECEIPT MAILED
Jul 23, 2019 MAFR
ASSIGNED TO EXAMINER
Jul 19, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 11, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 27, 2019 SDRC